Literature DB >> 7619220

Overexpression of MDM-2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines.

Y T Cheng1, Y L Li, J D Wu, S B Long, T S Tzai, C C Tzeng, M D Lai.   

Abstract

To investigate the importance of oncogenes and tumor suppressor genes in bladder carcinogenesis, we determined the status of the expression of the MDM-2 and p53 genes and genetic alterations in the p53 gene in five bladder carcinoma cell lines and one kidney urothelial carcinoma cell line. Overexpression of MDM-2 mRNA was observed in three bladder carcinoma cell lines, J82, SCaBER, and BFTC-905. Amplification of the MDM-2 gene was not detected in any of the six cell lines by southern analysis. The deletion in the p53 gene was observed in J82, and point mutation was detected in J82 and BFTC-909, the kidney urothelial carcinoma cell line. In contrast, no mutations were found in codons 12, 13, and 61 in the Ha-ras and Ki-ras genes in these six cell lines. These results indicate that alterations in the p53-regulated pathway are important in bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619220     DOI: 10.1002/mc.2940130307

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  11 in total

1.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.

Authors:  Shambhunath Choudhary; Kusum Rathore; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

Review 3.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

4.  Role of reactive oxygen species in proapoptotic ability of oncogenic H-Ras to increase human bladder cancer cell susceptibility to histone deacetylase inhibitor for caspase induction.

Authors:  Shambhunath Choudhary; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-09       Impact factor: 4.553

5.  Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.

Authors:  Paul L Severson; Erik J Tokar; Lukas Vrba; Michael P Waalkes; Bernard W Futscher
Journal:  Epigenetics       Date:  2012-09-13       Impact factor: 4.528

6.  The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Authors:  Chi-Chen Lu; Mei-Yi Lin; Syue-Yi Chen; Cheng-Huang Shen; Lih-Geeng Chen; Hsiao-Yen Hsieh; Michael W Y Chan; Cheng-Da Hsu
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

7.  H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells.

Authors:  C Li; R-H Teng; Y-C Tsai; H-S Ke; J-Y Huang; C-C Chen; Y-L Kao; C-C Kuo; W R Bell; B Shieh
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

8.  An investigation into the cytotoxic effects of 13-acetoxysarcocrassolide from the soft coral Sarcophyton crassocaule on bladder cancer cells.

Authors:  Ching-Chyuan Su; Jui-Hsin Su; Jen-Jie Lin; Cheng-Chi Chen; Wen-Ing Hwang; Han Hsiang Huang; Yu-Jen Wu
Journal:  Mar Drugs       Date:  2011-12-13       Impact factor: 6.085

9.  Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5.

Authors:  J-L Hsieh; C-L Wu; M-D Lai; C-H Lee; C-S Tsai; A-L Shiau
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

10.  Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer.

Authors:  Lea Weber; Wolfgang A Schulz; Stathis Philippou; Josephine Eckardt; Burkhard Ubrig; Michéle J Hoffmann; Andrea Tannapfel; Benjamin Kalbe; Günter Gisselmann; Hanns Hatt
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.